deltatrials
Completed EARLY_PHASE1 INTERVENTIONAL NCT00949845

Cytokine-Associated Depression and Social Pain

An fMRI Study of Cytokine-Associated Depression and Social Pain

Sponsor: University of California, Los Angeles

Conditions Depression
Interventions Endotoxin
Updated 5 times since 2017 Last updated: Jul 29, 2009 Started: Jan 31, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Depression and is currently completed. University of California, Los Angeles leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jan 2021 · 47 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed EARLY_PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed EARLY_PHASE1

  4. Feb 2017 — Jan 2021 [monthly]

    Completed EARLY_PHASE1

    Phase: Phase 0EARLY_PHASE1

  5. Jan 2017 — Feb 2017 [monthly]

    Completed Phase 0

    First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of California, Los Angeles
Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations